Skip to main content
logo
Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
6.87
-0.10 (-1.43%)
Mar 4, 2026, 3:42 PM EST - Market open

Telix Pharmaceuticals Revenue

In the year 2025, Telix Pharmaceuticals had annual revenue of $803.79M with 55.61% growth. Telix Pharmaceuticals had revenue of $413.44M in the half year ending December 31, 2025, with 115.29% growth.

Revenue (ttm)
$803.79M
Revenue Growth
+55.61%
P/S Ratio
2.80
Revenue / Employee
$678,880
Employees
1,184
Market Cap
2.25B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025803.79M287.24M55.61%
Dec 31, 2024516.55M183.57M55.13%
Jan 1, 2024332.98M224.17M206.01%
Dec 31, 2022108.81M103.29M1,870.12%
Dec 31, 20215.52M1.50M37.33%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Galapagos NV1.31B
Ultragenyx Pharmaceutical673.00M
Adaptive Biotechnologies276.98M
Stoke Therapeutics205.63M
Ascentage Pharma Group International54.52M
Ocular Therapeutix51.95M
Immunome9.68M
Dianthus Therapeutics3.08M
Revenue Rankings

TLX News

More News